General Information of the Drug (ID: M6APDG01088)
Name
8-O-(4-chlorobenzenesulfonyl)manzamine F
Synonyms
CHEMBL400717; 8-O-(4-chlorobenzenesulfonyl)manzamine F
    Click to Show/Hide
Status
Investigative
Structure
3D MOL
Formula
C42H47ClN4O5S
InChI
1S/C42H47ClN4O5S/c43-28-12-16-31(17-13-28)53(50,51)52-36-11-7-10-32-33-18-21-44-38(39(33)45-37(32)36)34-26-42(49)20-5-3-1-2-4-6-22-46-24-19-35(34)41(27-46)25-29-14-15-30(48)9-8-23-47(29)40(41)42/h1,3,7,10-13,16-18,21,26,29,35,40,45,49H,2,4-6,8-9,14-15,19-20,22-25,27H2/b3-1-/t29-,35?,40+,41-,42-/m0/s1
InChIKey
MSUMHGMGRZWLMN-WXPZYUJUSA-N
PubChem CID
23643731
TTD Drug ID
D00AAN
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Glycogen synthase kinase-3 beta (GSK-3B)
Fat mass and obesity-associated protein (FTO)
In total 1 mechanisms lead to this potential drug response
Response Summary Glycogen synthase kinase-3 beta (GSK-3B) is a therapeutic target for 8-O-(4-chlorobenzenesulfonyl)manzamine F. The Fat mass and obesity-associated protein (FTO) has potential in affecting the response of 8-O-(4-chlorobenzenesulfonyl)manzamine F through regulating the expression of Glycogen synthase kinase-3 beta (GSK-3B). [1], [2]
Methyltransferase-like 14 (METTL14)
In total 1 mechanisms lead to this potential drug response
Response Summary Glycogen synthase kinase-3 beta (GSK-3B) is a therapeutic target for 8-O-(4-chlorobenzenesulfonyl)manzamine F. The Methyltransferase-like 14 (METTL14) has potential in affecting the response of 8-O-(4-chlorobenzenesulfonyl)manzamine F through regulating the expression of Glycogen synthase kinase-3 beta (GSK-3B). [2], [3]
References
Ref 1 Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Front Cardiovasc Med. 2020 Nov 20;7:592550. doi: 10.3389/fcvm.2020.592550. eCollection 2020.
Ref 2 Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J Nat Prod. 2006 Jul;69(7):1034-40. doi: 10.1021/np0601399.
Ref 3 N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nat Commun. 2022 May 13;13(1):2672. doi: 10.1038/s41467-022-30217-7.